CareTrust REIT vs Diversified Healthcare Trust
CTRE and DHC side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CTRE and DHC compare
CareTrust REIT is the larger company, worth 4.5 times as much as Diversified Healthcare Trust ($8.6B against $1.9B).
CareTrust REIT grew revenue faster over the last twelve months (53.0% versus −1.5% for Diversified Healthcare Trust).
CareTrust REIT keeps more of each dollar of sales as profit, with a net margin of 62.2% compared with −17.7% at Diversified Healthcare Trust.
Both pay dividends: CareTrust REIT yields 4.1% and Diversified Healthcare Trust 0.50%.
CareTrust REIT scores higher on the StockData Score (15 against 1 for Diversified Healthcare Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CTRE | DHC |
|---|---|---|
| Size and price | ||
| Market cap | $8.6B | $1.9B |
| Share price | $36.39 | $7.97 |
| Change, 1 year | 7.1% | 91.1% |
| Change, 5 years | 72.5% | 123% |
| Beta (5Y) | 0.52 | 1.09 |
| Employees | 43 | 600 |
| StockData Score | ||
| Total score | 15 (better) | 1 |
| Valuation score | 2 (better) | 0 |
| Growth score | 4 (better) | 0 |
| Performance score | 4 (better) | 0 |
| Health score | 1 (better) | 0 |
| Dividend score | 4 (better) | 1 |
| Valuation | ||
| P/E | 22.9× | – |
| P/S | 15.0× | 1.3× (better) |
| P/B | 1.9× | 1.2× (better) |
| EV/EBITDA | 16.2× | 14.5× (better) |
| Fair value | $32.95 | $4.45 |
| Margin of safety | −10.4% (better) | −78.9% |
| Growth | ||
| Revenue growth (TTM) | 53.0% (better) | −1.5% |
| Revenue growth, 5Y average | 21.7% (better) | −1.2% |
| Net income growth (TTM) | 61.6% | – |
| EPS growth (TTM) | 32.5% | – |
| EPS growth, 5Y average | 13.1% | – |
| Profitability | ||
| Net margin | 62.2% (better) | −17.7% |
| Return on equity | 9.1% (better) | −15.5% |
| Financial health | ||
| Altman Z-score | 3.74 (better) | 1.13 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 4.1% (better) | 0.50% |
| Payout ratio | 85.9% | – |
| Years of dividend growth | 11 (better) | 0 |
| Dividend growth, 5Y average | 6.0% (better) | −26.0% |
| Buyback yield | −13.8% | 0.06% (better) |
| Shareholder yield | −9.7% | 0.56% (better) |
| Ownership | ||
| Held by institutions | 106% | 84.9% |
| Held by insiders | 0.99% | 15.2% |
| Insider net buying, 12 months | – | $97.8K |
| Short interest, % of float | 4.7% | – |
Go deeper
- CTRE stock overview
- CTRE income statement
- CTRE valuation and score
- DHC stock overview
- DHC income statement
- DHC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.